|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
GB9116610D0
(en)
|
1991-08-01 |
1991-09-18 |
Danbiosyst Uk |
Preparation of microparticles
|
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
WO2000053211A2
(en)
|
1999-03-09 |
2000-09-14 |
University Of Southern California |
Method of promoting myocyte proliferation and myocardial tissue repair
|
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
|
WO2001062299A2
(en)
|
2000-02-28 |
2001-08-30 |
Shearwater Corporation |
Water-soluble polymer conjugates of artelinic acid
|
|
US7097840B2
(en)
|
2000-03-16 |
2006-08-29 |
Genentech, Inc. |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
|
|
ES2605443T3
(es)
|
2003-11-06 |
2017-03-14 |
Seattle Genetics, Inc. |
Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia
|
|
NZ551180A
(en)
|
2004-06-01 |
2009-10-30 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
UA90480C2
(uk)
|
2004-07-22 |
2010-05-11 |
Джэнэнтэк, Инк. |
Фармацевтична композиція, що має протипухлинну активність, яка включає антитіло до her2
|
|
TR201808537T4
(tr)
|
2004-09-23 |
2018-07-23 |
Genentech Inc |
Sistein değiştirilmiş antikorlar ve konjugatlar.
|
|
JP5167473B2
(ja)
|
2005-03-03 |
2013-03-21 |
コヴェックス・テクノロジーズ・アイルランド・リミテッド |
抗血管新生化合物
|
|
EA016577B1
(ru)
|
2005-09-26 |
2012-06-29 |
Медарекс, Инк. |
Конъюгаты антитело-лекарство и их применение
|
|
US20100297103A1
(en)
|
2006-09-14 |
2010-11-25 |
Medical & Biological Laboratories Co., Ltd. |
Antibody having enhanced adcc activity and method for production thereof
|
|
US20090098115A1
(en)
*
|
2006-10-20 |
2009-04-16 |
Lisa Michele Crocker |
Cell lines and animal models of HER2 expressing tumors
|
|
BRPI0818780A2
(pt)
|
2007-10-19 |
2015-04-22 |
Genentech Inc |
Anticorpo anti-tenb2 planejados por cisteína e conjugados de medicamento com anticorpos
|
|
KR20100107501A
(ko)
|
2008-01-18 |
2010-10-05 |
메디뮨 엘엘씨 |
부위 특이적 접합을 위한 시스테인 조작 항체
|
|
DK2657253T3
(en)
|
2008-01-31 |
2017-10-09 |
Genentech Inc |
Anti-CD79b antibodies and immune conjugates and methods of use
|
|
BRPI1015234A2
(en)
|
2009-06-22 |
2018-02-20 |
Medimmune Llc |
fc regions designed for site specific conjugation.
|
|
CA3220104A1
(en)
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
|
ME02637B
(me)
|
2010-08-20 |
2017-06-20 |
Novartis Ag |
Antitela za receptor 3 faktora rasta epiderma (her3)
|
|
TW201302793A
(zh)
|
2010-09-03 |
2013-01-16 |
Glaxo Group Ltd |
新穎之抗原結合蛋白
|
|
CA2813411C
(en)
|
2010-11-05 |
2016-08-02 |
Rinat Neuroscience Corporation |
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
|
|
WO2012075581A1
(en)
|
2010-12-06 |
2012-06-14 |
Ym Biosciences Inc. |
Antibodies selective for cells presenting erbb2 at high density
|
|
US8852599B2
(en)
|
2011-05-26 |
2014-10-07 |
Bristol-Myers Squibb Company |
Immunoconjugates, compositions for making them, and methods of making and use
|
|
SG11201401699WA
(en)
|
2011-11-11 |
2014-09-26 |
Rinat Neuroscience Corp |
Antibodies specific for trop-2 and their uses
|
|
EP2780039B9
(en)
*
|
2011-11-17 |
2018-04-18 |
Pfizer Inc |
Cytotoxic peptides and antibody drug conjugates thereof
|
|
EP3539982B1
(en)
|
2011-12-23 |
2025-02-19 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
|
CA2871934C
(en)
|
2012-04-30 |
2023-06-13 |
Medimmune, Llc |
Molecules with reduced effector function and extended half-lives, compositions, and uses thereof
|
|
CN104822656B
(zh)
|
2012-05-15 |
2018-05-01 |
西雅图基因公司 |
自稳定接头偶联物
|
|
CA2879814A1
(en)
|
2012-08-02 |
2014-02-06 |
Jn Biosciences Llc |
Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece
|
|
WO2014022846A1
(en)
|
2012-08-03 |
2014-02-06 |
Board Of Regents Of The University Of Nebraska |
Cancer biomarkers and methods of use thereof
|
|
PT2906252T
(pt)
|
2012-10-12 |
2017-09-19 |
Medimmune Ltd |
Conjugados de anticorpo anti-her2 de pirrolobenzodiazepina
|
|
PT2906248T
(pt)
|
2012-10-12 |
2019-03-04 |
Medimmune Ltd |
Pirrolobenzodiazepinas e conjugados das mesmas
|
|
KR101763499B1
(ko)
|
2012-11-07 |
2017-07-31 |
화이자 인코포레이티드 |
항-il-13 수용체 알파 2 항체 및 항체-약물 접합체
|
|
EA201591465A1
(ru)
*
|
2013-02-08 |
2015-12-30 |
АйАрЭм ЭлЭлСи |
Специфичные участки для модификации антител для получения иммуноконъюгатов
|
|
MX363787B
(es)
|
2013-03-13 |
2019-04-03 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de los mismos.
|
|
WO2015002486A1
(ko)
|
2013-07-03 |
2015-01-08 |
서울대학교산학협력단 |
시스테인으로 변형된 닭의 항체 및 이를 이용한 부위-특이적 접합
|
|
BR112016002829A2
(pt)
|
2013-08-12 |
2017-09-19 |
Genentech Inc |
Composto e processo para preparar o composto de conjugado anticorpo-¿droga, composição farmacêutica, método de tratamento do câncer, kit para o tratamento do câncer, intermediário ligante¿-droga, porção e composto de porção droga de dímero cbi
|
|
WO2015038426A1
(en)
|
2013-09-13 |
2015-03-19 |
Asana Biosciences, Llc |
Self-immolative linkers containing mandelic acid derivatives, drug-ligand conjugates for targeted therapies and uses thereof
|
|
US9239324B2
(en)
|
2013-12-06 |
2016-01-19 |
Gang Chen |
Antibody-binding protein-drug conjugate and methods of use
|
|
AU2014372833B2
(en)
|
2013-12-23 |
2019-08-22 |
Bayer Pharma Aktiengesellschaft |
Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)
|
|
SG11201605437YA
(en)
|
2014-01-27 |
2016-08-30 |
Pfizer |
Bifunctional cytotoxic agents
|
|
DK3805268T3
(da)
*
|
2014-02-28 |
2025-01-20 |
Merus Nv |
Antistof, der binder erbb-2 og erbb-3
|
|
CA2943299A1
(en)
|
2014-04-11 |
2015-10-15 |
Medimmune, Llc |
Bispecific her2 antibodies
|
|
AU2015271100B2
(en)
*
|
2014-06-06 |
2020-07-30 |
Redwood Bioscience, Inc. |
Anti-HER2 antibody-maytansine conjugates and methods of use thereof
|
|
KR102046862B1
(ko)
|
2015-03-20 |
2019-11-20 |
화이자 인코포레이티드 |
Cti 약물작용발생단을 함유하는 이관능성 세포독성제
|
|
TWI812873B
(zh)
|
2015-11-30 |
2023-08-21 |
美商輝瑞股份有限公司 |
用於部位專一性接合之抗體和抗體片段
|